Keyword: Sato Yakuhin Kogyo

The FDA has again slammed a Japanese drug company in a warning letter, this time for not doing enough to prevent contamination during aseptic filling.

The FDA has issued a warning letter to a Chinese company it found peddling active pharmaceutical ingredients it had not manufactured or tested.